Zenas BioPharma (ZBIO) Shares Outstanding (Diluted) (2023 - 2026)
Zenas BioPharma (ZBIO) reported Weighted Average Shares Outstanding (Diluted) of 63.11 million for Q2 2026, up 50.8% from 41.87 million a year earlier and up 13.5% from the prior quarter.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
For FY2025, Zenas BioPharma posted Weighted Average Shares Outstanding (Diluted) of 44.73 million, up 238.9% from FY2024.
- By year, Weighted Average Shares Outstanding (Diluted) came in at 13.2 million in FY2024 (+762.0%) and 1.53 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q3 2023.
- Year over year, Weighted Average Shares Outstanding (Diluted) has now increased in each of the last four quarters, with growth averaging 306.3% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at 55.62 million (Q1 2026), 44.73 million (Q4 2025) and 42.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Zenas BioPharma | 1.94 Bn | 1.29 Bn | - | 66.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 66.15 Mn |
| Jun 30, 2026 | 63.11 Mn |
| Mar 31, 2026 | 55.62 Mn |
| Dec 31, 2025 | 44.73 Mn |
| Sep 30, 2025 | 42.16 Mn |
| Jun 30, 2025 | 41.87 Mn |
| Mar 31, 2025 | 41.80 Mn |
| Dec 31, 2024 | 13.20 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 1.90 Mn |
API Access
Zenas BioPharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();